A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy (Q44475552)

3 December 2017

A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy (English)

1 reference

3 December 2017

Acharya SK

1

1 reference

3 December 2017

Dasarathy S

series ordinal

2

1 reference

3 December 2017

Saksena S

series ordinal

3

1 reference

3 December 2017

Pande JN

series ordinal

4

1 reference

3 December 2017

1 September 1993

1 reference

3 December 2017

Journal of Hepatology

1 reference

3 December 2017

19

1 reference

3 December 2017

2

1 reference

3 December 2017

291-300

1 reference

Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices: a comparative study of results in patients with cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Noncirrhotic portal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Ulceration after esophageal and gastric variceal sclerotherapy--influence of sucralfate and other factors on healing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Prediction of variceal hemorrhage by esophageal endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Ultrasonography in portal hypertension: a sensitive noninvasive test to demonstrate portal-vascular anatomy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Sclerotherapy in extrahepatic portal venous obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

A Prospective Randomized Study of Two Sclerotherapy Techniques for Esophageal Varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

The role of propranolol in congestive gastropathy of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980585-9

7 January 2021

10.1016/S0168-8278(05)80585-9

Identifiers

DOI

1 reference

3 December 2017

1 reference